Assignee
ONK THERAPEUTICS LTD
IE·3 granted patents·7 pending applications·4 citations·filing 2018–2022
Top patents by PatentIndex Score
10 records- 0181US10960064B2Modified natural killer cells and natural killer cell lines having increased cytotoxicityONK THERAPEUTICS LTD·Filed 2018·Granted Mar 30, 2021·4 cites·16 claims
- 0261US12534536B2Natural killer cells expressing a chimeric antigen receptor that binds CD38ONK THERAPEUTICS LTD·Filed 2020·Granted Jan 27, 2026·0 cites·8 claims
- 0359US10906951B2Modified natural killer cells and natural killer cell lines having increased cytotoxicityONK THERAPEUTICS LTD·Filed 2018·Granted Feb 2, 2021·0 cites·9 claims
- 0457US2021138051A1Modified Natural Killer Cells and Natural Killer Cell Lines Having Increased CytotoxicityONK THERAPEUTICS LTD·Filed 2020·Application pending·0 cites
- 0555US2021230241A1Modified natural killer cells and natural killer cell lines having increased cytotoxicityONK THERAPEUTICS LTD·Filed 2020·Application pending·0 cites
- 0655US2023019381A1Nk cell-based therapyONK THERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 0747US2022143089A1Modified immune effector cells with increased resistance to cell deathONK THERAPEUTICS LTD·Filed 2020·Application pending·0 cites
- 0845US2023210903A1Hypoxia-resistant natural killer cellsONK THERAPEUTICS LTD·Filed 2020·Application pending·0 cites
- 0941US2024307443A1Double knockout natural killer cellsONK THERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 1040US2020392458A1Modified natural killer cells and natural killer cell lines targetting tumour cellsONK THERAPEUTICS LTD·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ONK THERAPEUTICS LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →